Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -16.36 is 92% above its 5-year average of -209.03, near the high end of its 5-year range (-450.95–99.15).
134.99% below its 12-month average of 46.76.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.87.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:58:07.626Z. Historical observations retain their original dates. Historical series through 2025-11-12.
EARNINGS PER SHARE (EPS)
-16.36
EARNINGS PER SHARE (EPS) AVG TTM
46.76
EARNINGS PER SHARE (EPS) AVG 3Y
-158.09
EARNINGS PER SHARE (EPS) AVG 5Y
-209.03
EARNINGS PER SHARE (EPS) AVG 10Y
-226.07
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-134.99%
CURRENT VS 3Y AVG
+89.65%
CURRENT VS 5Y AVG
+92.17%
CURRENT VS 10Y AVG
+92.76%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PAVmed Inc.
Market Cap
$17.07M
Earnings Per Share (EPS)
-16.36
TTM Avg
46.76
3Y Avg
-158.09
5Y Avg
-209.03
Market Cap
$16.84M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.99
3Y Avg
-1.87
5Y Avg
-3.18
Market Cap
$17.31M
Earnings Per Share (EPS)
-1.87
TTM Avg
-0.88
3Y Avg
-1.76
5Y Avg
-2.28
Market Cap
$16.82M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.07
3Y Avg
-1.56
5Y Avg
-1.55
Market Cap
$17.39M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$16.74M
Earnings Per Share (EPS)
-4.76
TTM Avg
-17.55
3Y Avg
-9.83
5Y Avg
-7.78
Market Cap
$16.64M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.52M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$18.30M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $17.07M | -16.36 | 46.76 | -158.09 | -209.03 |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -0.48 | -0.99 | -1.87 | -3.18 |
| Lipocine Inc. (LPCN)vs › | $17.31M | -1.87 | -0.88 | -1.76 | -2.28 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -0.91 | -1.07 | -1.56 | -1.55 |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -0.66 | -0.90 | -9.28 | -9.88 |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -4.76 | -17.55 | -9.83 | -7.78 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -3.73 | -46.49 | -194.14 | -195.03 |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -0.21 | -0.22 | -0.25 | -0.30 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | -0.25 | -0.29 | -0.28 | -0.20 |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -0.76 | -2.06 | -5.59 | -9.29 |
Trailing EPS (TTM)
$-16.36
Forward EPS (Est.)
$-3.62
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.63 |
| 2024-12-31 | 99.15 |
| 2023-12-31 | -274.92 |
| 2022-12-31 | -450.95 |
| 2021-12-31 | -293.92 |
| 2020-12-31 | -327.91 |
| 2019-12-31 | -249.27 |
| 2018-12-31 | -378.78 |
| 2017-12-31 | -346.50 |
| 2016-12-31 | -198.00 |
| 2015-12-31 | -60.07 |
| 2014-12-31 | -9.18 |
